ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,683.00
-0.01%
S&P ASX All Technology
3,008.10
0.02%
Brent Oil
86.685
-0.61%
US Dollar vs AUD
1.5387
-0.03%
Bitcoin
63,396.39
-1.38%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) News

AVDL Avadel Pharmaceuticals PLC

17.1042
-0.5558 (-3.15%)
Last Updated: 00:54:58
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Avadel Pharmaceuticals PLC AVDL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.5558 -3.15% 17.1042 00:54:58
Open Price Low Price High Price Close Price Previous Close
17.56 16.95 17.56 17.66
more quote information »

Recent News

Date Time Source Heading
01/4/202423:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
06/3/202400:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
05/3/202407:51EDGAR2Form 8-K - Current report
05/3/202407:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
04/3/202422:35EDGAR2Form 8-K - Current report
04/3/202422:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202400:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
14/2/202423:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202400:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202400:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
17/1/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:20EDGAR2Form 8-K - Current report
08/1/202423:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
30/12/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202306:54EDGAR2Form 144 - Report of proposed sale of securities
09/11/202301:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:09EDGAR2Form 8-K - Current report
08/11/202323:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
08/11/202300:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
30/10/202323:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/10/202323:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
05/10/202323:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
02/9/202311:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202311:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202322:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
16/8/202306:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202307:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202305:50EDGAR2Form 144 - Report of proposed sale of securities
11/8/202308:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202323:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202321:37EDGAR2Form 8-K - Current report
09/8/202321:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/8/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:15EDGAR2Form 8-K - Current report
04/8/202306:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
03/8/202321:30EDGAR2Form 8-K - Current report
02/8/202322:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
21/7/202306:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
07/7/202306:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..

Your Recent History

NASDAQ
AVDL
Avadel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved